| Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response S Bachiller, I Jiménez-Ferrer, A Paulus, Y Yang, M Swanberg, ... Frontiers in cellular neuroscience 12, 488, 2018 | 672 | 2018 |
| Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation MA Burguillos, M Svensson, T Schulte, A Boza-Serrano, ... Cell reports 10 (9), 1626-1638, 2015 | 320 | 2015 |
| Targeting neuroinflammation to treat Alzheimer’s disease A Ardura-Fabregat, E Boddeke, A Boza-Serrano, S Brioschi, ... CNS drugs 31, 1057-1082, 2017 | 237 | 2017 |
| Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease A Boza-Serrano, R Ruiz, R Sanchez-Varo, J García-Revilla, Y Yang, ... Acta neuropathologica 138, 251-273, 2019 | 223 | 2019 |
| Inflammation leads to distinct populations of extracellular vesicles from microglia Y Yang, A Boza-Serrano, CJR Dunning, BH Clausen, KL Lambertsen, ... Journal of neuroinflammation 15, 1-19, 2018 | 156 | 2018 |
| Forced treadmill exercise can induce stress and increase neuronal damage in a mouse model of global cerebral ischemia M Svensson, P Rosvall, A Boza-Serrano, E Andersson, J Lexell, ... Neurobiology of stress 5, 8-18, 2016 | 144 | 2016 |
| Alpha-synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models M Djelloul, S Holmqvist, A Boza-Serrano, C Azevedo, MS Yeung, ... Stem cell reports 5 (2), 174-184, 2015 | 128 | 2015 |
| The role of Galectin-3 in α-synuclein-induced microglial activation A Boza-Serrano, JF Reyes, NL Rey, H Leffler, L Bousset, U Nilsson, ... Acta neuropathologica communications 2, 1-14, 2014 | 114 | 2014 |
| Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer’s disease mouse model 5xFAD A Boza-Serrano, Y Yang, A Paulus, T Deierborg Scientific reports 8 (1), 1550, 2018 | 112 | 2018 |
| Hyperinflammation and fibrosis in severe COVID-19 patients: galectin-3, a target molecule to consider J Garcia-Revilla, T Deierborg, JL Venero, A Boza-Serrano Frontiers in Immunology 11, 572082, 2020 | 95 | 2020 |
| APOE in the bullseye of neurodegenerative diseases: Impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases R Fernández-Calle, SC Konings, J Frontiñán-Rubio, J García-Revilla, ... Molecular neurodegeneration 17 (1), 62, 2022 | 89 | 2022 |
| Fumarate decreases edema volume and improves functional outcome after experimental stroke BH Clausen, L Lundberg, M Yli-Karjanmaa, NA Martin, M Svensson, ... Experimental neurology 295, 144-154, 2017 | 48 | 2017 |
| Divergent effects of metformin on an inflammatory model of Parkinson’s disease K Tayara, AM Espinosa-Oliva, I García-Domínguez, AA Ismaiel, ... Frontiers in cellular neuroscience 12, 440, 2018 | 47 | 2018 |
| FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes E Savchenko, GN Teku, A Boza-Serrano, K Russ, M Berns, T Deierborg, ... Scientific reports 9 (1), 9610, 2019 | 35 | 2019 |
| Galectin-3 causes enteric neuronal loss in mice after left sided permanent middle cerebral artery occlusion, a model of stroke X Cheng, A Boza-Serrano, MF Turesson, T Deierborg, E Ekblad, U Voss Scientific Reports 6 (1), 32893, 2016 | 33 | 2016 |
| Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration J García-Revilla, A Boza-Serrano, AM Espinosa-Oliva, MS Soto, ... Cell death & disease 13 (7), 628, 2022 | 30 | 2022 |
| Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease A Boza-Serrano, A Vrillon, K Minta, A Paulus, L Camprubí-Ferrer, ... Acta neuropathologica 144 (5), 843-859, 2022 | 25 | 2022 |
| Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: a preliminary study KT Kovacs, SR Kalluri, A Boza-Serrano, T Deierborg, T Csepany, M Simo, ... Multiple Sclerosis Journal 22 (9), 1192-1201, 2016 | 20 | 2016 |
| The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease I Jimenez-Ferrer, F Bäckström, A Duenas-Rey, M Jewett, A Boza-Serrano, ... Brain, Behavior, and Immunity 91, 369-382, 2021 | 16 | 2021 |
| Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke H Gredal, BB Thomsen, A Boza-Serrano, L Garosi, C Rusbridge, ... Neuroreport 28 (3), 134-140, 2017 | 16 | 2017 |
